|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 207/337 | (2006.01) |
| A61P 9/10 | (2018.01) | ||
| C07D 401/12 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 27/00 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 19/02 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| A61P 27/00 | (2006.01) | ||
| C07D 207/34 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07F 9/65583 | (2013.01) |
| (11) | Number of the document | 3807245 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19819804.6 |
| Date of filing the European patent application | 2019-06-13 | |
| (97) | Date of publication of the European application | 2021-04-21 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/037067 |
| Date | 2019-06-13 |
| (87) | Number | WO 2019/241567 |
| Date | 2019-12-19 |
| (30) | Number | Date | Country code |
| 201862684681 P | 2018-06-13 | US |
| (72) |
BEAUSOLEIL, Anne-Marie , US
HUDSON, Ryan , US
|
| (73) |
Unity Biotechnology, Inc. ,
285 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (54) | ACYL SULFONAMIDES THAT ARE BCL FAMILY ANTAGONISTS FOR USE IN CLINICAL MANAGEMENT OF CONDITIONS CAUSED OR MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER |
| ACYL SULFONAMIDES THAT ARE BCL FAMILY ANTAGONISTS FOR USE IN CLINICAL MANAGEMENT OF CONDITIONS CAUSED OR MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER |